scholarly journals Evaluation and Classification Risks of Implementing Blockchain in the Drug Supply Chain with a New Hybrid Sorting Method

2021 ◽  
Vol 13 (20) ◽  
pp. 11466
Author(s):  
Parisa Sabbagh ◽  
Rana Pourmohamad ◽  
Marischa Elveny ◽  
Mohammadali Beheshti ◽  
Afshin Davarpanah ◽  
...  
Keyword(s):  
Supply Chain ◽  
Literature Review ◽  
Technology Implementation ◽  
Integrated System ◽  
Drug Supply ◽  
Point Of Sale ◽  
Blockchain Technology ◽  
Medical Supplies ◽  
Wide Range ◽  
Drug Supply Chain

In blockchain technology, all registered information, from the place of production of the product to its point of sale, is recorded as permanent and unchangeable, and no intermediary has the ability to change the data of other members and even the data registered by them without public consensus. In this way, users can trust the accuracy of the data. Blockchain systems have a wide range of applications in the medical and health sectors, from creating an integrated system for recording and tracking patients’ medical records to creating transparency in the drug supply chain and medical supplies. However, implementing blockchain technology in the supply chain has limitations and sometimes has risks. In this study, BWM methods and VIKORSort have been used to classify the risks of implementing blockchain in the drug supply chain. The results show that cyberattacks, double spending, and immutability are very dangerous risks for implementation of blockchain technology in the drug supply chain. Therefore, the risks of blockchain technology implementation in the drug supply chain have been classified based on a literature review and opinions of the experts. The risks of blockchain technology implementation in the supply chain were determined from the literature review.

scholarly journals A Novel Medical Blockchain Model for Drug Supply Chain Integrity Management in a Smart Hospital

Electronics ◽  
2019 ◽  
Vol 8 (5) ◽  
pp. 505 ◽  
Author(s):  
Faisal Jamil ◽  
Lei Hang ◽  
KyuHyung Kim ◽  
DoHyeun Kim
Keyword(s):  
Developing Countries ◽  
Supply Chain ◽  
Drug Supply ◽  
Counterfeit Drugs ◽  
Pharmaceutical Supply Chain ◽  
Blockchain Technology ◽  
Smart Healthcare ◽  
Drug Regulations ◽  
Pass Through ◽  
Drug Supply Chain

At present, in pharmacology one of the most serious problems is counterfeit drugs. The Health Research Funding organization reported that in developing countries, nearly 10–30% of the drugs are fake. Counterfeiting is not the main issue itself, but, rather, the fact that, as compared to traditional drugs, these counterfeit drugs produce different side effects to human health. According to WHO, around 30% of the total medicine sold in Africa, Asia, and Latin America is counterfeit. This is the major worldwide problem, and the situation is worse in developing countries, where one out of every 10 medicines are either fake or do not follow drug regulations. The rise of Internet pharmacies has made it more difficult to standardize drug safety. It is difficult to detect counterfeits because these drugs pass through different complex distributed networks, thus forming opportunities for counterfeits to enter the authentic supply chain. The safety of the pharmaceutical supply chain has become a major concern for public health, which is a collective process. In this paper, we propose a novel drug supply chain management using Hyperledger Fabric based on blockchain technology to handle secure drug supply chain records. The proposed system solves this problem by conducting drug record transactions on a blockchain to create a smart healthcare ecosystem with a drug supply chain. A smart contract is launched to give time-limited access to electronic drug records and also patient electronic health records. We also carried out a number of experiments in order to demonstrate the usability and efficiency of the designed platform. Finally, we used Hyperledger Caliper as a benchmarking tool to conduct the performance of the designed system in terms of transactions per second, transaction latency, and resource utilization.

scholarly journals Blockchain technology for digitalization of the pharmaceutical sector of the Russian Federation

2021 ◽  
Vol 291 ◽  
pp. 02028
Author(s):  
Ahad Qodirov
Keyword(s):  
Supply Chain ◽  
Pharmaceutical Products ◽  
Drug Supply ◽  
Technological Solution ◽  
Decentralized System ◽  
Blockchain Technology ◽  
Transportation Process ◽  
The Russian Federation ◽  
Drug Supply Chain

One of the main priorities of the modern healthcare system is the transportation of pharmaceutical products. The drug supply chain consists of many participants. These are drug manufacturers, intermediary organizations, and end users. The biggest problems associated with this transportation are temperature monitoring and the quality of the offered products. This is because many drugs and vaccines remain viable within a certain temperature range. As soon as the temperature regime during transportation is violated, the quality of the medicine decreases sharply. In this article, the author proposes the use of Blockchain technology to solve these problems and focuses on improving the transportation process. In his opinion, a decentralized system based on Blockchain technology is the best technological solution. In addition, the author is developing a concept for the application of Blockchain technologies to create a functioning medical ecosystem.

scholarly journals Requirements Identification for a Blockchain-Based Traceability Model for Animal-Based Medicines

2021 ◽  
Vol 9 (1) ◽  
pp. 11
Author(s):  
Rodrigo S. Aranda ◽  
Roberto F. Silva ◽  
Carlos E. Cugnasca
Keyword(s):  
Supply Chain ◽  
Raw Materials ◽  
Current Situation ◽  
Drug Supply ◽  
Traceability System ◽  
Blockchain Technology ◽  
Approval Time ◽  
Drug Supply Chain ◽  
Requirements Identification

In this paper, the traceability of heparin medicine will be studied. Currently, the registration of traceability data is conducted in a decentralized manner. With blockchain implementation, the traceability systems that use this data could become semi-automated, increasing the quality, security, and confidence of the information generated in the supply chain. This paper presents the essential requirements and activities wherein information must be collected within the heparin drug supply chain, focusing on the animal raw materials production link and its requirements. Blockchain technology is proposed to increase traceability and reliability in relation to the current situation. It also fulfills all the requirements identified if used as part of a traceability system. These requirements are: the existence of a consensus mechanism; anonymity; protocol, efficiency, and consumption; immutability; ownership and management; and approval time. We conclude the paper by presenting the mapping of requirements and entities and critical activities for adopting blockchain technology to support the traceability of raw materials from animals used in heparin production.

US trade policy is putting at risk the sustainability of the generic/biosimilar industry and the drug supply chain

2021 ◽  
pp. 174113432199431
Author(s):  
María Fabiana Jorge
Keyword(s):  
Supply Chain ◽  
Trade Policy ◽  
Pharmaceutical Products ◽  
Drug Supply ◽  
Active Pharmaceutical Ingredients ◽  
Pharmaceutical Ingredients ◽  
Us Trade Policy ◽  
Drug Supply Chain ◽  
Security Concern ◽  
The U.S

With the outbreak of the Coronavirus there is a new realization of the vulnerabilities of the U.S. drug supply chain. However, while such concerns may have been amplified by the pandemic, they preceded Covid-19 and were well documented before 2020. Indeed, in past years the U.S. Congress held several hearings addressing potential vulnerabilities in the U.S. drug supply chain, in part due to the increasing dependency on China as a dominant supplier of active pharmaceutical ingredients (APIs) and some finished pharmaceutical products. These vulnerabilities go well beyond health policy and constitute a national security concern. The article addresses how U.S. trade policy plays a significant role in shaping the pharmaceutical industry at home and abroad and is in part responsible for some of the current vulnerabilities of the U.S. drug supply chain.

scholarly journals On Deploying Blockchain Technologies in Supply Chain Strategies and the COVID-19 Pandemic: A Systematic Literature Review and Research Outlook

2021 ◽  
Vol 13 (19) ◽  
pp. 10566
Author(s):  
Mohammad Nabipour ◽  
M. Ali Ülkü
Keyword(s):  
Supply Chain ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Web Of Science ◽  
Environmental Issues ◽  
Future Studies ◽  
Blockchain Technology ◽  
Industrial Sectors ◽  
Holistic Review ◽  
Review Study

The emergence of a new pandemic, known as COVID-19, has touched various sections of the supply chain (SC). Since then, numerous studies have been conducted on the issue, but the need for a holistic review study that highlights the gaps and limits of previous research, as well as opportunities and agendas for future studies, is palpable. Through a systematic literature review on blockchain technology (BCT) deployment in supply-chain management (SCM) concerning the COVID-19 pandemic, this research seeks to add to the content of previous studies and to enlighten the path for future studies. Relevant papers were found using a variety of resources (Scopus, Google Scholar, Web of Science, and ProQuest). Seventy-two articles were systematically selected, considering the PRISMA procedure, and were thoroughly analyzed based on BCT, methodologies, industrial sectors, geographical, and sustainability context. According to our findings, there is a significant lack of empirical and quantitative methodologies in the literature. The majority of studies did not take specific industries into account. Furthermore, the articles focusing on the sustainability context are few, particularly regarding social and environmental issues. In addition, most of the reviewed papers did not consider the geographical context. The results indicate that the deployment of BCT in several sectors is not uniform, and this utilization is reliant on their services during the COVID-19 pandemic. Furthermore, the concentration of research on the impacts of the BCT on SCM differs according to the conditions of various countries in terms of the consequences of the COVID-19 pandemic. The findings also show that there is a direct relationship between the deployment of BCT and sustainability factors, such as economic and waste issues, under the circumstances surrounding COVID-19. Finally, this study offers research opportunities and agendas to help academics and other stakeholders to gain a better knowledge of the present literature, recognize aspects that necessitate more exploration, and drive prospective studies.

scholarly journals Optimizing Drug Supply Chain in Hospital Pharmacy Department: An Empirical Evidence from a Developing Country

2015 ◽  
Vol 5 (2) ◽  
pp. 153 ◽  
Author(s):  
John Mensah ◽  
Jonathan Annan ◽  
David Asamoah
Keyword(s):  
Supply Chain ◽  
Best Practices ◽  
Hospital Pharmacy ◽  
Primary Data ◽  
Drug Supply ◽  
Queuing Model ◽  
Pharmacy Department ◽  
The World ◽  
Reduced Costs ◽  
Drug Supply Chain

<p class="ber"><span lang="EN-GB">Healthcare organisations all over the world are looking for ways to improve operational efficiencies at reduced costs without affecting their services. This study was undertaken to first and foremost examine the supply chain practices at KATH Pharmacy, and secondly to assess those practices in the light of industrially accepted best practices. Primary data was obtained from fifty-five (55) respondents and the data were analysed using SPSS, and queuing model. </span><span lang="EN-US">Interesting findings emerged from the study, including patients spending an average of 12 minutes within the system of drug dispensing unit. However, this time can be reduced if the numbers of servers within the facility is increased by way of opening more dispensing outlets.</span></p>

Sign in / Sign up

Export Citation Format

Share Document